BNP Paribas Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.4K Sell
488
-86
-15% -$7.28K ﹤0.01% 1921
2026
Q1
$57.1K Buy
+574
New +$74.9K ﹤0.01% 1712

Other funds holding TMDX

BNP Paribas Asset Management's TMDX Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Transmedics (TMDX) stake by 15% in Q2 2026, selling an estimated $7.28K and leaving 488 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

BNP Paribas Asset Management first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $57.1K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • BNP Paribas Asset Management held 488 shares of Transmedics worth $32.4K as of Q2 2026.
  • BNP Paribas Asset Management sold 86 Transmedics shares in Q2 2026, an estimated $7.28K.
  • Transmedics made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1921 holding.
  • BNP Paribas Asset Management first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • BNP Paribas Asset Management's Transmedics position peaked at $57.1K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.